These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9725078)

  • 1. Neuroreceptor imaging: new developments in PET and SPECT imaging of neuroreceptor binding (including dopamine transporters, vesicle transporters and post synaptic receptor sites).
    Stoessl AJ; Ruth TJ
    Curr Opin Neurol; 1998 Aug; 11(4):327-33. PubMed ID: 9725078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single photon emission computed tomography imaging of dopaminergic function: presynaptic transporter, postsynaptic receptor, and "intrasynaptic" transmitter.
    Innis RB
    Adv Pharmacol; 1998; 42():215-9. PubMed ID: 9327882
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons.
    Dresel SH; Kung MP; Huang XF; Plössl K; Hou C; Meegalla SK; Patselas G; Mu M; Saffer JR; Kung HF
    J Nucl Med; 1999 Apr; 40(4):660-6. PubMed ID: 10210226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
    Miller DK; Crooks PA; Zheng G; Grinevich VP; Norrholm SD; Dwoskin LP
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1035-45. PubMed ID: 15121762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study.
    Augood SJ; Hollingsworth Z; Albers DS; Yang L; Leung JC; Muller B; Klein C; Breakefield XO; Standaert DG
    Neurology; 2002 Aug; 59(3):445-8. PubMed ID: 12177384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo imaging of the vesicular acetylcholine transporter and the vesicular monoamine transporter.
    Efange SM
    FASEB J; 2000 Dec; 14(15):2401-13. PubMed ID: 11099458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo snapshots of the dopaminergic synapse in small animals.
    Nikolaus S; Beu M; Wirrwar A; Antke C; Müller HW
    Mol Psychiatry; 2005 Jun; 10(6):516-8. PubMed ID: 15920466
    [No Abstract]   [Full Text] [Related]  

  • 8. Imaging of monoaminergic and cholinergic vesicular transporters in the brain.
    Frey KA; Wieland DM; Kilbourn MR
    Adv Pharmacol; 1998; 42():269-72. PubMed ID: 9327896
    [No Abstract]   [Full Text] [Related]  

  • 9. Brain radioligands--state of the art and new trends.
    Halldin C; Gulyás B; Langer O; Farde L
    Q J Nucl Med; 2001 Jun; 45(2):139-52. PubMed ID: 11476163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporters and neuronal injury.
    Miller GW; Gainetdinov RR; Levey AI; Caron MG
    Trends Pharmacol Sci; 1999 Oct; 20(10):424-9. PubMed ID: 10498956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automatic segmentation of dynamic neuroreceptor single-photon emission tomography images using fuzzy clustering.
    Acton PD; Pilowsky LS; Kung HF; Ell PJ
    Eur J Nucl Med; 1999 Jun; 26(6):581-90. PubMed ID: 10369943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholamine reuptake and storage. Overview.
    Bönisch H; Eiden L
    Adv Pharmacol; 1998; 42():149-64. PubMed ID: 9327868
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of the haloperidol tetrahydropyridine metabolite 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6- tetrahydropyridine on dopamine receptor and transporter binding. A nonhuman primate 123I-iodobenzamide and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane single photon emission computed tomographic study.
    Oliver DW; Dormehl IC; Van der Schyf CJ; Neumeyer JL; Hugo N; Keeve R; Rossouw NT; Müller-Gärtner HW; Castagnoli N
    Arzneimittelforschung; 1997 Jun; 47(6):692-9. PubMed ID: 9239444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism.
    Booij J; Tissingh G; Winogrodzka A; van Royen EA
    Eur J Nucl Med; 1999 Feb; 26(2):171-82. PubMed ID: 9933352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters.
    Neumeyer JL; Wang S; Gao Y; Milius RA; Kula NS; Campbell A; Baldessarini RJ; Zea-Ponce Y; Baldwin RM; Innis RB
    J Med Chem; 1994 May; 37(11):1558-61. PubMed ID: 8201589
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic genes and substance abuse.
    Uhl GR; Vandenbergh DJ; Rodriguez LA; Miner L; Takahashi N
    Adv Pharmacol; 1998; 42():1024-32. PubMed ID: 9328073
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.
    Brooks DJ; Frey KA; Marek KL; Oakes D; Paty D; Prentice R; Shults CW; Stoessl AJ
    Exp Neurol; 2003 Nov; 184 Suppl 1():S68-79. PubMed ID: 14597329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptors and transporters in Parkinson's disease and schizophrenia.
    Seeman P; Niznik HB
    FASEB J; 1990 Jul; 4(10):2737-44. PubMed ID: 2197154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional imaging of neurotransmitter systems in movement disorders.
    Ilgin N
    Q J Nucl Med; 1998 Sep; 42(3):179-92. PubMed ID: 9796366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.